key: cord-0876244-russ710r
authors: Hinze, Christian; Kocks, Christine; Leiz, Janna; Karaiskos, Nikos; Boltengagen, Anastasiya; Skopnik, Christopher Mark; Klocke, Jan; Hardenberg, Jan-Hendrik; Stockmann, Helena; Gotthardt, Inka; Obermayer, Benedikt; Haghverdi, Laleh; Wyler, Emanuel; Landthaler, Markus; Bachmann, Sebastian; Hocke, Andreas C.; Corman, Victor; Busch, Jonas; Schneider, Wolfgang; Himmerkus, Nina; Bleich, Markus; Eckardt, Kai-Uwe; Enghard, Philipp; Rajewsky, Nikolaus; Schmidt-Ott, Kai M.
title: Transcriptomic responses of the human kidney to acute injury at single cell resolution
date: 2021-12-16
journal: bioRxiv
DOI: 10.1101/2021.12.15.472619
sha: de0046cee459b8d549053e431a95f1c62172c35c
doc_id: 876244
cord_uid: russ710r

Background Acute kidney injury (AKI) occurs frequently in critically ill patients and is associated with adverse outcomes. Cellular mechanisms underlying AKI and kidney cell responses to injury remain incompletely understood. Methods We performed single-nuclei transcriptomics, bulk transcriptomics, molecular imaging studies, and conventional histology on kidney tissues from 8 individuals with severe AKI (stage 2 or 3 according to Kidney Disease: Improving Global Outcomes (KDIGO) criteria). Specimens were obtained within 1-2 hours after individuals had succumbed to critical illness associated with respiratory infections, with 4 of 8 individuals diagnosed with COVID-19. Control kidney tissues were obtained post-mortem or after nephrectomy from individuals without AKI. Results High-depth single cell-resolved gene expression data of human kidneys affected by AKI revealed enrichment of novel injury-associated cell states within the major cell types of the tubular epithelium, in particular in proximal tubules, thick ascending limbs and distal convoluted tubules. Four distinct, hierarchically interconnected injured cell states were distinguishable and characterized by transcriptome patterns associated with oxidative stress, hypoxia, interferon response, and epithelial-to-mesenchymal transition, respectively. Transcriptome differences between individuals with AKI were driven primarily by the cell type-specific abundance of these four injury subtypes rather than by private molecular responses. AKI-associated changes in gene expression between individuals with and without COVID-19 were similar. Conclusion The study provides an extensive resource of the cell type-specific transcriptomic responses associated with critical illness-associated AKI in humans, highlighting recurrent disease-associated signatures and inter-individual heterogeneity. Personalized molecular disease assessment in human AKI may foster the development of tailored therapies.

Acute kidney injury (AKI) is a frequently observed clinical syndrome, which associates with high morbidity and mortality [1] [2] [3] [4] [5] [6] . More than 10% of all hospitalized individuals and more than 50% of critically ill individuals admitted to intensive care units develop AKI 2, 3, 7 . Despite its extensive clinical and economic impact, AKI therapy is largely limited to best supportive care and kidney replacement therapies (hemodialysis or hemofiltration) in patients with advanced kidney failure [8] [9] [10] . Targeted therapies preventing AKI or fostering recovery from AKI are still missing.

Numerous attempts have been made using animal models and human samples to uncover underlying mechanisms of AKI, to identify therapeutic targets and to identify disease biomarkers [11] [12] [13] [14] [15] [16] [17] . However, studies in a controlled clinical setting with cell type-specific gene expression resolution of human AKI are lacking.

Although AKI is uniformly defined by changes in serum creatinine levels and/or urinary output, previous studies suggest a vast underlying heterogeneity and complexity of AKI with an unknown number of AKI subtypes, suggesting that personalized approaches in the treatment of AKI may be needed 15, [18] [19] [20] . Most recently, the question of AKI subtypes was intensively debated when high incidence rates of AKI were observed in individuals with COVID-19 [21] [22] [23] [24] . In particular the question was raised whether COVID-19 entails a specific molecular subtype of AKI, either through renal viral tropism or other systemic effects [25] [26] [27] [28] [29] .

Single-cell gene expression approaches provide powerful tools to investigate cell typespecific changes and cellular interactions and thus may help to delineate potential molecular subtypes of AKI. Recent mouse studies underlined the potential of single cell resolution for our understanding of AKI and revealed new molecular cell states associated with AKI 11, 12, 30 . Here, we present the first comparative single cell census of the human kidney in individuals with AKI compared to controls without AKI.

To access cellular responses in AKI, we conducted a single cell transcriptome census of human AKI utilizing single-nuclei RNA sequencing (snRNA-seq) of kidney samples from individuals with AKI and control individuals without AKI (Fig. 1A) . Kidney samples from individuals with AKI who succumbed to critical illness were obtained within 1-2 hours post-mortem with consent of next of kin. All AKI individuals (n=8, AKI1-8) had developed clinical criteria of severe AKI (as defined by KDIGO criteria for AKI stage 2 or stage 3) within 5 days prior to sampling. All individuals had developed AKI in a clinical setting of critical illness, severe respiratory infections, and systemic inflammation, including four cases of COVID-19-associated AKI (Suppl . Table S1 ).

To control for baseline characteristics inherent to human kidneys obtained under clinical conditions and to quantitate the extent of post-mortem effects on gene expression, we used control kidney samples. They included normal kidney tissue collected during tumor nephrectomies (n=3; ControlTN1-TN3; for clinical parameters of all individuals see Suppl. Table S1 ). In addition, we obtained post-mortem kidney tissue at three different time points (15 min, 60 min, 120 min) after the cessation of circulation (Control15 min; 60 min; 120 min) from a brain-dead individual without clinical evidence of AKI.

Single-nuclei RNA-seq of all samples resulted in 106,971 sequenced cells with a median of 2139 detected genes and 4008 unique transcripts per cell (Suppl. Fig. S1 ). Joint unbiased clustering and cell type identification with known marker genes allowed the identification of the expected major kidney cell types ( Fig. 1B-D) . There were no overt differences in major cell type abundances between AKI and controls (Fig. 1E ). Principal component analysis (PCA) indicated that the presence of AKI (versus absence of clinical AKI) was the main driver of cell type-specific and global gene expression differences between the samples (Fig. 1F, Suppl. Fig. S2 ). In contrast, PCA did not identify a major impact of the sampling method (tumor versus post-mortem biopsy), the sampling time after cessation of circulation (15 min, 60 min or 120 min) or the presence of COVID-19-associated AKI (versus AKI associated with other respiratory infections) on global or cell-type-specific gene expression (Fig. 1F, Suppl. Fig S2) . Interestingly, we observed heterogeneity of kidney cell gene expression between different individuals with AKI, suggesting different molecular subtypes of AKI (Fig. 1F ). 

Kidney ischemia-reperfusion injury in mice, the most frequently applied experimental model of human AKI, results in a predominant injury of cells of the proximal tubule (PT), the most abundant cell type of the kidney. Therefore, many previous studies focused on this cell type 13, 14 .

However, in humans there is considerable uncertainty regarding the impact of AKI on molecular states of different kidney cell types 31 . To assess the cell type-specific response to AKI systematically, we performed differential gene expression analysis within the major kidney cell types comparing AKI to control kidneys using DESeq2 32 (see Suppl. Table S2 for a full list of differentially expressed genes per cell type). Profound transcriptomic responses to AKI were observed in kidney tubule cells of the PT, the thick ascending limb of the loop of Henle (TAL), the distal convoluted tubule (DCT), and connecting tubules (CNT), cell types that reside predominantly in the cortex and outer medulla of the kidney, regions that are known to be particular susceptible to ischemic or hypoxic injury [13] [14] [15] 33 (Fig. 2A) . In contrast, less pronounced transcriptomic responses to AKI were observed in thin limbs (tL), collecting duct principal cells (CD-PCs) and collecting duct intercalated cells (CD-ICs), consistent with the predominant localization of these cell types in the inner medulla of the kidney, which is adapted to a low oxygen environment, has lower energy expenditure and is less susceptible to hypoxia or ischemia when compared to more cortical regions 33 . Podocytes, endothelial cells and interstitial cells also displayed less pronounced transcriptomic responses in AKI.

Among differentially expressed genes were known markers of renal cell stress, which encode proteins that have been proposed as kidney injury markers, such as neutrophil gelatinaseassociated lipocalin/lipocalin 2 (LCN2), kidney injury molecule 1 (HAVCR1), and insulin-like growth factor binding protein 7 (IGFBP7) 34 . Importantly, our data provided the opportunity to identify the major cellular sources where these transcripts were synthesized in response to injury.

For instance, consistent with previous reports on mouse and human AKI, LCN2 was primarily upregulated in CNT and CD-PC 12,35 , while HAVCR1 was primarily upregulated in PT 12, 36 (Fig. 2B ).

Secreted phosphoprotein 1 (SPP1), encoding for the secreted glycoprotein osteopontin, was found to be upregulated in virtually all non-leukocyte kidney cell types. This was strongly reminiscent of the situation in mouse AKI, where osteopontin upregulation was similarly observed in multiple kidney cell types 12 , and where osteopontin inhibition attenuated renal injury 37 , suggesting a conserved, targetable AKI pathway. IGFBP7 protein was previously found to be primarily of PT origin in diseased human kidneys 38 . Consistently, we found an upregulation of IGFBP7 mRNA in PT cells (Fig. 2B) . However, we also found IGFBP7 to be upregulated in podocytes and TALs (Fig. 2B ), findings which we were able to validate by IGFBP7 in situ hybridization (Suppl. Fig. S3 ). This indicates that our single cell transcriptome database is consistent with prior knowledge and provides an opportunity to uncover novel information regarding the cellular origin of AKI-associated transcripts.

Pathway analyses of differentially expressed genes indicated that a proportion of genes upregulated in AKI were associated with inflammatory response-associated pathways (tumor necrosis factor alpha, interferon gamma and interleukin signaling), hypoxia response, and epithelial to mesenchymal transition (EMT, Fig. 2C , Suppl. Table S3 ). Importantly, our analyses indicated that most functional pathways were upregulated simultaneously in multiple kidney tubule cell types suggesting common AKI response patterns across the nephron. Several studies have indicated an AKI-associated metabolic shift in tubular epithelia and a downregulation of genes associated with tubular transport processes 33, 39 . Consistently, we observed that genes downregulated in AKI were mostly related to molecule transport and metabolism (Fig. 2D ).

Since our cohort included four individuals with COVID-19-associated AKI, we compared their kidney cell type-specific gene expression with that of individuals with non-COVID-19 respiratory infection-associated AKI. Only few differentially expressed genes were identified, suggesting that the major transcriptomic responses of kidney cells in COVID-19 were not substantially different from those in other forms of AKI (see Suppl. Table S4 for the respective gene lists).

Importantly, the genes and pathways that were differentially regulated in AKI versus control according to single nuclei sequencing data displayed concordant regulation in bulk mRNA sequencing from separate kidney samples of the same patients, providing additional validation 

To achieve a more fine-grained analysis of cellular subclasses, we performed subclusterings of the major kidney cell types. Thereby, we were able to derive 74 kidney cell populations based on their transcriptomes, which included known cellular subtypes of kidney cells (e. g. S1, S2, and S3 segments of the PT) and additional novel cell populations (designated as "New" cell populations, Fig. 3 , Suppl. Fig. S4 -5). These "New" cell populations were still attributable to major kidney cell types based on their transcriptomes (Fig. 1C ), but they were not characteristic of the known anatomic sub cell types, suggesting that they represent injury-related cell states.

We analyzed, which of the identified cell subpopulations differed in abundance in individuals with AKI, yielding depleted and enriched subpopulations (Fig. 3B ). Profound depletion in AKI was observed within cells of the PT (in particular those representing the S3 segment), consistent with its known susceptibility to injury and its tendency to undergo dedifferentiation in AKI 11, 13, 14, 40 . Unexpectedly, in addition to PT, differentiated medullary TAL, DCT, CNT cells were also substantially depleted in AKI. Inversely, profound enrichment in AKI was observed of the "New" cell subpopulations associated with these same cell types, indicating that PT, TAL, DCT and CNT displayed the most profound responses to AKI and confirming the notion that "New" subpopulations represent injury-associated cell states ( 

We next conducted further analyses to characterize the "New" cell subpopulations detected within the tubular epithelial compartment of the kidney. Quantification of the four "New" cell clusters associated with the PT (PT-New 1-4) indicated that almost one third (31.8%) of PT cells in AKI samples belonged to these clusters (Fig. 4A ). We next identified marker genes for PT-New 1-4 ( We compared PT-New 1-4 to previously identified PT-derived injured cell states in mouse renal ischemia-reperfusion injury, designated as "injured PT S1/S2 cells", "injured PT S3 cells", "severe injured PT cells" and "failed repair" cells 11 . We trained a multinomial model using marker genes of these clusters using a cross-species mouse/human comparative approach (see methods), which indicated that PT-New 1 (oxidative stress) showed similarity to injured mouse S1/2 cells, whereas PT-New 2 (hypoxia) resembled injured S3 cells (Suppl. Fig. S6 ). PT-New 3 and PT-New 4 most closely resembled "failed repair" PT cells in mice (Suppl. Fig. S6 ). Cells from PT-New 3 and PT-New 4 expressed the EMT marker VIM. PT-New 4 cells were additionally marked by VCAM1, a marker that has previously been associated with the "failed repair" state of injured PT cells 42 . PT-New 1, PT-New 3 and PT-New 4 also showed high expression of interferon target genes (e. g. IFITM2, IFITM3) and human leukocyte antigen HLA-A, which is consistent with the association of injured PT cells with immune responses and inflammation 42 . Together these observations suggest that "New" cell populations represent four distinct but hierarchically connected injured PT cell states.

The individual abundances of PT-New 1-4 and the combined abundances of PT-New 1-4 were significantly increased in the AKI samples (Fig. 4C, D) . Importantly, the distribution of PT-New 1-4 among individuals with AKI displayed marked heterogeneity (Fig. 4C, E) . For instance, the relative abundance of PT-New 4 (EMT/ "failed repair") varied by a factor of three among samples from different individuals with AKI (compare PT-New 4 between AKI 4 and AKI 7 in Fig.   4E ). The combined injury-associated PT clusters (PT-New 1-4) made up between 20% and 45% of all proximal tubule cells in individuals with AKI (Fig. 4C ). Together these observations highlight the presence of recurrent AKI-associated cell states, but they also indicate substantial interindividual heterogeneity.

To localize "New" PT-associated clusters in injured kidney tissues, we performed RNAscope in situ hybridizations for transcripts overexpressed in PT-New 1-4 clusters (Fig. 4F ).

Interleukin-18 (IL18) mRNA was specifically expressed in occasional cells within clusters PT-New 2 and PT-New 4. Consistently, in situ hybridizations indicated that IL18 mRNA was expressed in a small subpopulation of PT cells of AKI kidneys compared with little or no expression in control kidneys (Fig. 4F) . In contrast, insulin-like growth factor binding protein 7 (IGFBP7) was widely expressed in PT-New 1-4 cells. Consistently, in situ hybridizations of AKI kidneys demonstrated IGFBP7 mRNA expression in a substantial subset of PT cells (Fig. 4F) , while only few PT cells of control kidneys expressed IGFBP7. Interferon-induced transmembrane protein 3 (IFITM3) was expressed in a subset of cells within PT-New 1, 3, and 4. In situ hybridization confirmed IFITM3 expression within severely injured PT cells of AKI kidneys, while IFITM3 was undetectable in control kidneys (Fig. 4F) . 

We next turned to other kidney epithelial cell types and their response to injury. We compared AKI-enriched "New" cell states in tL, TAL, DCT, CNT, CD-PC and CD-IC to those in PT (Fig. 5, Suppl. Fig. S7-9) . Remarkably, the transcriptomic responses of the different tubular epithelial cell types to AKI displayed a marked overlap. For instance, "New" cell populations Similar to the PT, we also observed inter-individual heterogeneity for the AKI-associated cell states in other cell types of the kidney tubule (Fig. 5E, Suppl. Fig. S7-9) . Although, similar clusters as PT-New 1-4 were present in the other kidney tubule cell types, their relative abundance was cell type-dependent. In PTs and DCTs, the most abundant AKI-associated cell state was that associated with EMT (PT-New 4 and DCT-New 4). In contrast, the most abundant TAL cell state was TAL-New 3 (interferon gamma signaling-associated). IFITM3, an interferon-associated gene and marker gene of TAL-New 3, was expressed in injured TALs of AKI kidneys when analyzed by in situ hybridization (Fig. 5F ). We conclude that injury responses in different epithelial cell types of the kidney associate with common molecular pathways and marker genes, although they display cell type-specific and inter-individual heterogeneity. 

This study identifies a strong impact of human AKI associated with critical illness on the kidney transcriptome at single cell resolution. We provide an atlas of single cell transcriptomes and uncover novel AKI-induced transcriptomic responses at unprecedented cellular resolution and transcriptional depth. We find that the dominant AKI-associated transcriptomic alterations reside within the different cell types of the kidney's tubular epithelium with surprisingly few transcriptomic alterations in other cell types. We uncover four AKI-associated "New" transcriptomic cell states, which emerge abundantly in PT, TAL and DCT and display a remarkable overlap of marker genes and enriched molecular pathways between these different tubular epithelial cell types, suggesting common injury mechanisms. Finally, we report a strong transcriptional heterogeneity among individuals with AKI, which is explained by the inter-individual differences in cell type-specific abundances of injury-associated cell states.

Our study provides insights into the pathophysiology of human AKI and indicates injuryassociated responses in several different types of tubular epithelial cells. Previous studies of AKI in animal models (mostly ischemia-reperfusion injury in mice) have focused on the PT because cells of the PT are abundant and because PTs display marked susceptibility and responsiveness to ischemic injury 13, 14, 31, 33, [43] [44] [45] . Fewer studies have examined effects of AKI on other cell types.

However, some previous rodent studies also showed evidence of injury in distal parts of the kidney tubule including TALs 46 and collecting ducts 47 , similar to what we demonstrate here in human AKI.

Presumed mechanisms of tubular injury and tubular transcriptome responses are related to the high metabolic demands of tubular cells, in particular proximal tubules and TALs, which become overwhelmed in the setting of ischemia or hypoxia 31, 46, 48, 49 . Tubular stress in this setting is documented by novel induction of injury-associated transcripts and down-regulation of differentiation markers (e. g. solute transporters). Most recently, transcriptome studies at single cell resolution in mouse AKI models confirmed these findings and indicated predominant cellular responses in the proximal tubule compartment of the kidney 11, 12, 30 . Our human AKI data are consistent with the proximal tubular responses described in mice, but they suggest an unexpectedly widespread molecular response in other types of kidney tubular epithelia, including TAL, DCT, CNT and collecting duct. It is tempting to assume that this difference reflects the more complex, multifactorial pathogenesis of AKI in critically ill patients compared to ischemia reperfusion models, but additional interspecies differences can so far not be excluded.

Given the observed induction of AKI-associated cell states in different segments of the kidney tubule, questions arise regarding their functional significance. It is noteworthy that we found a particularly pronounced activation of NRF2 target genes in the "New 1" clusters in several cell types (PT-New 1, TAL-New 1, DCT-New 1, CNT-New 1, CD-PC-New 1, TL-New 1). NRF2 signaling is induced by oxidative stress, plays a role in the induction of antioxidative genes and has been associated with protection from kidney injury [50] [51] [52] . Trajectory analyses and comparative genomics indicated that these cells were likely derived from S1/2 segments of the PT and represent an early stage of injury. Cells of the "New 2" cluster exhibited a hypoxia signature.

Hypoxia has also previously been recognized as an important mechanism of AKI, due to low baseline tissue oxygen concentrations in the kidney, which further decline under conditions leading to AKI. Induction of hypoxia-inducible genes through stabilization of hypoxia-inducible transcription factors in different kidney cell populations or selectively in TAL or PT cells was found to ameliorate ischemic or toxic AKI 33, 53 . In contrast, cells of the "New 3" and "New 4" clusters expressed an EMT signature and pro-inflammatory genes and resembled cells previously described as a "failed repair" state, which is associated with progression to kidney fibrosis 11, 42 . In trajectory analyses these cells were transcriptionally most distant from healthy tubular epithelium in PT and TAL.

Our study included patients with COVID-19-associated AKI. There is an ongoing debate on the mechanisms of AKI in COVID-19, particularly with regard to whether there is a COVID-19-specific kidney pathophysiology that is different from other critical illness-associated forms of AKI 26,28,54,55 .

Our study did not uncover a specific transcriptomic signature associated with COVID-19associated AKI and suggests that COVID-19 AKI is on a common molecular spectrum with AKI associated with other types of respiratory failure and critical illness.

In summary, we observed that AKI in humans with critical illness and systemic inflammation is associated with widespread transcriptomic responses within a spectrum of kidney cell types, uncovering novel cell states and potential targets for AKI therapies. These findings suggest that precision approaches like single cell transcriptomics maybe suitable tools to overcome the current limitations in diagnosing and treating subtypes of AKI.

After consent of next of kin, post mortem biopsies were collected using 18G biopsy needles within 2 hours from death from individuals who had died in a clinical setting of critical illness on intensive care units of Charité-Universitaetsmedizin Berlin (ethics approval EA2/045/18) (see Suppl. Table S1 for detailed patient characteristics). Control tissue from tumor-adjacent normal tissue of tumor nephrectomies was collected during tumor nephrectomies (ethics approval EA4/026/18). Kidney specimen were either stored in pre-cooled RNAlater at 4°C for 24 hours and then stored at -80°C (for snRNA-seq) or in 4% formaldehyde (for histopathological studies and in situ hybridizations).

Kidney specimen subjected to snRNA-seq were kept at 4°C at all times. All specimens were treated as described in detail in Leiz, Hinze et al. 2021 56 .

Main steps included: Specimens were thoroughly minced in nuclear lysis buffer 1 (nuclear lysis buffer (Sigma) + Ribolock (1U/µl) + VRC (10mM)) and homogenated using a dounce homogenizer with pastel A (Sigma D8938-1SET), filtered (100 µm), homogenized again (douncer with pastel B), filtered through a 35 µm strainer and centrifuged (5 min, 500g). The pellet was then resuspended in nuclear lysis buffer 2 (nuclear lysis buffer + Ribolock (1U/µl)). To remove debris from the suspension, we underlayed the suspension with lysis buffer containing 10% sucrose and 1U/µl of Ribolock. After centrifugation (5 min, 500g), the supernatant and debris were carefully removed. Pelleted nuclei were resuspended in PBS/0.04%BSA + Ribolock (1U/µl), filtered through a 20 µm strainer and stained with DAPI.

All samples were subjected to single-nuclei sequencing following the 10x genomics protocol for Chromium Next GEM Single Cell 3' v3.1 chemistry targeting 10000 nuclei. Obtained libraries were sequenced on Illumina HiSeq 4000 sequencers (paired-end). Digital expression matrices were generated using the Cellranger software version 3.0.2 with -force-cells 10000 against a genome composed of the human HG38 genome (GRCh38 3.0.0).

Initial filtering was performed by excluding nuclei with more than 5% mitochondrial reads and less than 500 detected genes. Nuclei passing this filter of all samples were then analyzed using Seurat's best practice work flow for data integration using the reciprocal PCA approach my.result = results(dds, contrast=c("condition","Control","AKI")) Results were then filtered by demanding adjusted p-value<0.001 and absolute log2 fold change larger than 2.

Differentially expressed genes were analyzed, separately, for genes up-and downregulated in AKI versus controls using the MSigDB web interface:

http://www.gsea-msigdb.org/gsea/msigdb/annotate.jsp with the hallmark gene sets and curated gene sets (C1) from Biocarta, Kegg, Reactome and

WikiPathways.

The full integrated assay from the Seurat object of the respective cell type were imported into scanpy version 1.5.0. PCA and neighborhood graph were computed:

sc.tl.pca(data, use_highly_variable=False) sc.pp.neighbors(data, n_pcs=30)

Healthy subclusters (e.g. PT-S1-3) were summarized into one category (e.g. Healthy PT)

to exclude the anatomical axis from this analysis. PAGA graph and diffusion pseudotime (dpt)

were calculated. The root of diffusion pseudotime was defined to be in the first element of the healthy cells (e.g. first element in healthy PT). To further exclude the anatomic axis from pseudotime analysis, all dpt values for the healthy cells were set to 0. PAGA graph was then plotted with threshold 0.15 highlighting dpt. Dpt was min-max normalized for plotting.

Mouse ischemia reperfusion data was downloaded from GEO (GSE139107) 11 , meta data of PT subclustering from the original publication was kindly provided by Ben Humphreys.

Multinomial classification was performed using the glmnet package version 2.0-16. The training set included randomly selected cells (2/3 of cells) from injured mouse PT subclusterings (Suppl. Fig. S6 ). Genes used in the training were highly variable features of the mouse AKI data. Human orthologous genes were generated using Biomart. Test data were the remaining 1/3 of mouse PT injured subclusters. Glmnet produces different models for different values of lambda which determines how hard overcomplexity of the respective model gets punished. Each so-generated model was tested on the test data and the model with the highest accuracy on the test data was determined. The so selected model was then applied to our human PT subclusters PT-New 1-4.

The RNAscope 2.5 HD reagent kit-brown (#322300, Advanced Cell Diagnostics (ACD), Newark, CA) was used to perform chromogenic in situ hybridization on formalin-fixed paraffin embedded mouse kidney sections with probes directed against IFITM3 (#1062531-C1, ACD), IGFBP7 (#316681, ACD) and IL18 (#400301, ACD).

Kidney slices were fixed in 4% formaldehyde embedded in paraffin by the Department of Pathology of Charité-Universitaetsmedizin Berlin. Paraffin-embedded kidney slices were cut into 5 µm sections, plated on Superfrost Plus slides, air-dried overnight, baked for 1 hour at 60°C, cooled for 30 minutes, dewaxed, and air-dried again. Subsequent pretreatment and RNAscope assay procedures for all probes were performed according to the "Formalin-Fixed Paraffin-Embedded (FFPE) Sample Preparation and Pretreatment" and "RNAscope 2.5 HD Detection Reagent BROWN" protocols (ACD documents #322452 and #322310) as recommended by the manufacturer. Sections were counterstained with hematoxylin before dehydrating and applying coverslips using a xylene-based mounting medium. Images of the hybridized sections were captured on a Leica DM2000 LED bright field microscope.

Acute kidney injury associates with increased long-term mortality

Acute kidney injury and mortality in hospitalized patients

Intermediate and Long-term Outcomes of Survivors of Acute Kidney Injury Episodes: A Large Population-Based Cohort Study

Acute kidney injury, mortality, length of stay, and costs in hospitalized patients

Mortality after acute renal failure: models for prognostic stratification and risk adjustment

Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey

Acute renal failure in critically ill patients: a multinational, multicenter study

Novel Therapies for Acute Kidney Injury

Management of Acute Kidney Injury: Core Curriculum

Continuous renal replacement therapy: recent advances and future research

Cell profiling of mouse acute kidney injury reveals conserved cellular responses to injury

Single-Cell Profiling of AKI in a Murine Model Reveals Novel Transcriptional Signatures, Profibrotic Phenotype, and Epithelial-to-Stromal Crosstalk

Tubular Epithelial NF-kappaB Activity Regulates Ischemic AKI

Canonical BMP signaling in tubular cells mediates recovery after acute kidney injury

Unique Transcriptional Programs Identify Subtypes of AKI

Biomarkers of Acute and Chronic Kidney Disease

Urinary EGF and MCP-1 and risk of CKD after cardiac surgery

Rationale and design of the Kidney Precision Medicine Project

Acute kidney injury subphenotypes based on creatinine trajectory identifies patients at increased risk of death

Recovery after Acute Kidney Injury

Critical Illness and Systemic Inflammation Are Key Risk Factors of Severe Acute Kidney Injury in Patients With COVID-19

Acute kidney injury in patients hospitalized with COVID-19

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

Acute kidney injury in critically ill patients with COVID-19

SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule

SARS-CoV-2 renal tropism associates with acute kidney injury

Kidney Biopsy Findings in Patients with COVID-19

COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings

Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective Cohort

Single-nuclear transcriptomics reveals diversity of proximal tubule cell states in a dynamic response to acute kidney injury

Experimental ischemia-reperfusion: biases and myths-the proximal vs. distal hypoxic tubular injury debate revisited

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Kidney physiology and susceptibility to acute kidney injury: implications for renoprotection

The Role of Biomarkers in Acute Kidney Injury

The Ngal reporter mouse detects the response of the kidney to injury in real time

Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury

Osteopontin Blockade Attenuates Renal Injury After Ischemia Reperfusion by Inhibiting NK Cell Infiltration

Insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinases-2: differential expression and secretion in human kidney tubule cells

Metabolic reprogramming and tolerance during sepsis-induced AKI

Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure

PAGA: graph abstraction reconciles clustering with trajectory inference through a topology preserving map of single cells

Single cell transcriptional and chromatin accessibility profiling redefine cellular heterogeneity in the adult human kidney

Effect of glycine and hypertrophy on renal outer medullary hypoxic injury in ischemia reflow and contrast nephropathy

Protective role of furosemide and saline in radiocontrast-induced acute renal failure in the rat

Mouse models and methods for studying human disease, acute kidney injury (AKI)

Proximal tubular injury attenuates outer medullary hypoxic damage: studies in perfused rat kidneys

Acute kidney injury in the diabetic rat: studies in the isolated perfused and intact kidney

Hypoxia of the renal medulla--its implications for disease

The role of medullary ischemia in acute renal failure

Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression

Clinical review: oxygen as a signaling molecule

The role of Nrf2 in acute kidney injury: Novel molecular mechanisms and therapeutic approaches

Hypoxia-inducible transcription factors stabilization in the thick ascending limb protects against ischemic acute kidney injury

AKI in Hospitalized Patients with and without COVID-19: A Comparison Study

The spectrum of kidney biopsies in hospitalized patients with COVID-19, acute kidney injury, and/or proteinuria

Nuclei Isolation from Adult Mouse Kidney for Single-Nucleus RNA-Sequencing

featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

This work was supported by grants to KMSO We thank Tatjana Luganskaja for excellent technical support. We thank Benjamin D.Humphreys and his lab for providing supplemental information to their original publication 11 .